Centers for Medicare and Medicaid Services Publishes Draft Coverage Decision to Reimburse the Decipher® Test for Intermediate & High Risk Prostate Cancer |
October 17, 2014 | October 2014 Bond Updates |
SAN DIEGO, Oct. 16, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment... |
View more at: http://www.prnewswire.com/news-releases/centers-for-medicare-and-medicaid-services-publishes-draft-coverage-decision-to-reimburse-the-decipher-test-for-intermediate--high-risk-prostate-cancer-279518912.html |
Related News |
|